Thermo Fisher Scientific has introduced value-priced AmpSure Universal SYBR Green and Probe Master Mixes, designed for compatibility with existing qPCR instruments and workflows, according to the company.
Seegene has introduced a syndromic PCR-based test for simultaneous detection of STIs and HPV. Company data show co-detection in 71% of positive cases, supporting potential clinical utility for comprehensive reproductive infection screening.
The test uses a new approach to identify signs of cancer recurrence with faster result times for healthcare providers and patients.
The technology is designed to deliver high-purity long RNA to support CRISPR and functional genomics workflows.
Read More
New kit cuts sample-to-result time to 75 minutes while maintaining sensitivity for drug metabolism studies.
Read More
The new module enables one-step reverse transcription and amplification, removing cDNA prep and supporting applications in translational research, cell and gene therapy manufacturing, and diagnostic development.
Read More
The GeneSight test results led to faster initial remission and response in patients with major depressive disorder, with benefits persisting over six months.
Read More
The collaboration combines Profluent’s generative AI platform with IDT’s enzyme engineering and genomics expertise to accelerate development of next-generation enzymes.
Read More
A novel reverse transcriptase is designed to offer a more complete view of the transcriptome by overcoming decades-old technical hurdles in sample preparation.
Read More
The French diagnostics company announced the clearance allows healthcare professionals to collect specimens by swabbing only the anterior part of the nasal cavity.
Read More
The program focuses on antibiotic resistance in urinary tract infections, with applications open until Nov 20.
Read More
The funding will support commercialization of the company’s extracellular vesicle-based liquid biopsy tests, starting with ovarian cancer screening.
Read More
The DNA-based stool screening test is now authorized for marketing through the MHRA, expanding access to non-invasive CRC detection.
Read More
A collaborative study has developed a low-cost, open-source, lyophilized RT-LAMP assay for pathogen detection.
Read More
Researchers have developed a CRISPR-Cas10-integrated graphene biosensor for amplification-free, ultra-sensitive RNA and miRNA detection.
Read More
Diasorin has launched the Simplexa C. auris Direct kit to aid in identifying Candida auris and enhance infection control.
Read More
A new study informed use of PARP inhibitors beyond BRCA1/2-deficient tumors and reevaluated biomarkers for PARP inhibition in prostate cancer.
Read More
The USPTO granted Sherlock Biosciences a patent for the diagnostic use of the Cas12 enzyme, establishing it as CRISPR diagnostics provider.
Read More